Probucol: Pharmacology and Clinical Application

Beyond Cholesterol

1989 • 6,533 citations

Regulation of Plasma Cholesterol by Lipoprotein Receptors

1981 • 958 citations

New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.

1987 • 196 citations

Plasma mevalonate as a measure of cholesterol synthesis in man.

1984 • 163 citations

Multifactorial Primary Prevention of Cardiovascular Diseases in Middle-aged Men

1985 • 154 citations

Effects of probucol on homozygous cases of familial hypercholesterolemia

1983 • 113 citations

Scanning electron microscopy in the evaluation of endothelial integrity of the fatty lesion in atherosclerosis

1976 • 89 citations

Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia

1980 • 78 citations

In vivo inhibition of foam cell development by probucol in Watanabe rabbits

1988 • 71 citations

Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesions

1988 • 62 citations

Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol quantitative regression Swedish trial (PQRST): A status report

1988 • 61 citations

Pathophysiology of lipoprotein transport

1978 • 61 citations

Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.

1989 • 59 citations

Lipoprotein oxidation and cytotoxicity: Effect of probucol on streptozotocin-treated rats

1988 • 49 citations

Effect of probucol on development of diabetes mellitus in BB rats

1988 • 45 citations

Pharmacology and toxicology of probucol.

1982 • 44 citations

Probucol enhances cholesterol efflux from cultured human skin fibroblasts

1988 • 42 citations

Effect of Probucol on Hyperlipidemia in Patients with Nephrotic Syndrome

1987 • 37 citations

Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease

1986 • 29 citations

Lovastatin: An HMG-CoA Reductase Inhibitor for Lowering Cholesterol

1989 • 23 citations

Probucol in the long-term treatment of hypercholesterolaemia

1973 • 21 citations

Safety and effectiveness of probucol as a cholesterol lowering agent.

1982 • 21 citations

Increased levels of messenger ribonucleic acid for apolipoprotein E in the spleen of probucol-treated rabbits

1988 • 20 citations

Probucol in long-term treatment of hypercholesterolemia

1988 • 20 citations

Probucol, high-density lipoprotein metabolism and reverse cholesterol transport

1988 • 18 citations

Controlled studies of the efficacy and safety of combined probucol-colestipol therapy

1986 • 16 citations

Probucol enhances cholesterol transport in cultured rat hepatocytes

1988 • 16 citations

Nine years of treatment with probucol.

1982 • 13 citations

Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.

1986 • 7 citations

Mode of hypocholesterolemic action of probucol in animals and man.

1987 • 7 citations